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Endothelium-dependent dilatations are due mainly to the release of nitric oxide (NO) 
which is formed by the constitutive endothelial NO synthase (eNOS). NO diﬀuses to 
the underlying vascular smooth muscle and stimulates soluble guanylyl cyclase with 
the resulting production of cyclic GMP. The release of NO from the endothelium can be 
mediated by both pertussis toxin-sensitive Gi- (e.g. α2-adrenergic agonists, serotonin) 
and insensitive Gq- (adenosine diphosphate, bradykinin) proteins. The ability of the 
endothelial cell to release NO can be down-regulated by oxidative stress and increased 
presence of oxidized low density lipoproteins (LDL). It is reduced chronically by aging, 
smoking, environmental pollution and in hypertension and diabetes. Following injury 
or apoptotic death, the endothelium regenerates. However, in regenerated endothelial 
cells, there is an early selective loss of the pertussis-toxin sensitive mechanisms of 
NO-release. Functional studies suggest that abnormal handling of LDL because of 
increased oxidative stress play a key role in this selective loss. Genomic analysis 
demonstrates the emergence of fatty acid binding protein-A (A-FABP)) in regenerated 
endothelial cells. To verify the role of oxidative stress and A-FABP in the genesis of 
coronary atherosclerosis, endothelial regeneration was induced in the coronary artery of 
pigs treated chronically with BMS309403 (A-FABP inhibitor) or apocynin (anti-oxidant) 
for 28 days before functional examination and histological analysis of the coronary 
arteries (with native or regenerated endothelium). Both the antioxidant treatment and 
inhibition of A-FABP normalized the diminished Gi-protein mediated relaxations to 
serotonin and reduced the intima-medial thickening caused by endothelial regeneration. 
These treatments did not aﬀect the response to bradykinin or endothelium-independent 
agonists (detaNONOate and isoproterenol). These experiments conﬁrm the crucial role 
of oxidative stress and of the emergence of A-FABP in the initiation of endothelial 
dysfunction and subsequent coronary atherosclerosis.
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